vs
Koppers Holdings Inc.（KOP）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい（$493.8M vs $432.7M、Koppers Holdings Inc.の約1.1倍）。Koppers Holdings Inc.の純利益率が高く（6.9% vs 6.8%、差は0.0%）。Pediatrix Medical Group, Inc.の前年同期比売上増加率が高い（-1.7% vs -9.3%）。過去8四半期でPediatrix Medical Group, Inc.の売上複合成長率が高い（-0.1% vs -6.7%）
コッパーズ・ホールディングスは、アメリカ合衆国ペンシルベニア州ピッツバーグに本拠を置くグローバルな化学・素材企業です。本社は1920年代に建てられたアールデコ調の超高層ビル「コッパーズタワー」に入居し、世界各国で事業を展開しています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
KOP vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $432.7M | $493.8M |
| 純利益 | $29.7M | $33.7M |
| 粗利率 | 25.6% | — |
| 営業利益率 | 11.5% | 9.9% |
| 純利益率 | 6.9% | 6.8% |
| 売上前年比 | -9.3% | -1.7% |
| 純利益前年比 | 391.2% | 10.5% |
| EPS（希薄化後） | $1.44 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $432.7M | $493.8M | ||
| Q3 25 | $485.3M | $492.9M | ||
| Q2 25 | $504.8M | $468.8M | ||
| Q1 25 | $456.5M | $458.4M | ||
| Q4 24 | $477.0M | $502.4M | ||
| Q3 24 | $554.3M | $511.2M | ||
| Q2 24 | $563.2M | $504.3M | ||
| Q1 24 | $497.6M | $495.1M |
| Q4 25 | $29.7M | $33.7M | ||
| Q3 25 | $23.8M | $71.7M | ||
| Q2 25 | $16.4M | $39.3M | ||
| Q1 25 | $-13.9M | $20.7M | ||
| Q4 24 | $-10.2M | $30.5M | ||
| Q3 24 | $22.8M | $19.4M | ||
| Q2 24 | $26.8M | $-153.0M | ||
| Q1 24 | $13.0M | $4.0M |
| Q4 25 | 25.6% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 23.2% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 21.6% | — | ||
| Q1 24 | 19.3% | — |
| Q4 25 | 11.5% | 9.9% | ||
| Q3 25 | 10.7% | 13.8% | ||
| Q2 25 | 7.7% | 12.8% | ||
| Q1 25 | 5.9% | 7.0% | ||
| Q4 24 | 1.3% | 7.8% | ||
| Q3 24 | 9.0% | 6.6% | ||
| Q2 24 | 10.2% | -31.3% | ||
| Q1 24 | 7.0% | 3.2% |
| Q4 25 | 6.9% | 6.8% | ||
| Q3 25 | 4.9% | 14.5% | ||
| Q2 25 | 3.2% | 8.4% | ||
| Q1 25 | -3.0% | 4.5% | ||
| Q4 24 | -2.1% | 6.1% | ||
| Q3 24 | 4.1% | 3.8% | ||
| Q2 24 | 4.8% | -30.3% | ||
| Q1 24 | 2.6% | 0.8% |
| Q4 25 | $1.44 | $0.40 | ||
| Q3 25 | $1.17 | $0.84 | ||
| Q2 25 | $0.81 | $0.46 | ||
| Q1 25 | $-0.68 | $0.24 | ||
| Q4 24 | $-0.47 | $0.37 | ||
| Q3 24 | $1.09 | $0.23 | ||
| Q2 24 | $1.25 | $-1.84 | ||
| Q1 24 | $0.59 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | — | $375.2M |
| 総負債低いほど良い | $928.3M | $570.5M |
| 株主資本純資産 | $574.0M | $865.9M |
| 総資産 | $1.9B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.62× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
| Q4 25 | $928.3M | $570.5M | ||
| Q3 25 | $932.9M | $577.2M | ||
| Q2 25 | $977.5M | $583.9M | ||
| Q1 25 | $989.0M | $590.5M | ||
| Q4 24 | $939.5M | $597.1M | ||
| Q3 24 | $989.4M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $877.6M | — |
| Q4 25 | $574.0M | $865.9M | ||
| Q3 25 | $545.6M | $890.7M | ||
| Q2 25 | $526.8M | $833.8M | ||
| Q1 25 | $498.0M | $789.2M | ||
| Q4 24 | $488.7M | $764.9M | ||
| Q3 24 | $532.3M | $732.5M | ||
| Q2 24 | $509.2M | $706.5M | ||
| Q1 24 | $505.8M | $856.2M |
| Q4 25 | $1.9B | $2.2B | ||
| Q3 25 | $1.9B | $2.2B | ||
| Q2 25 | $1.9B | $2.1B | ||
| Q1 25 | $1.9B | $2.0B | ||
| Q4 24 | $1.9B | $2.2B | ||
| Q3 24 | $2.0B | $2.1B | ||
| Q2 24 | $1.9B | $2.0B | ||
| Q1 24 | $1.8B | $2.2B |
| Q4 25 | 1.62× | 0.66× | ||
| Q3 25 | 1.71× | 0.65× | ||
| Q2 25 | 1.86× | 0.70× | ||
| Q1 25 | 1.99× | 0.75× | ||
| Q4 24 | 1.92× | 0.78× | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 1.97× | — | ||
| Q1 24 | 1.74× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $45.1M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $28.5M | — |
| FCFマージンFCF / 売上 | 6.6% | — |
| 設備投資強度設備投資 / 売上 | 3.8% | — |
| キャッシュ転換率営業CF / 純利益 | 1.52× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $67.5M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $45.1M | $114.1M | ||
| Q3 25 | $49.6M | $137.3M | ||
| Q2 25 | $50.5M | $137.2M | ||
| Q1 25 | $-22.7M | $-117.5M | ||
| Q4 24 | $74.7M | $133.0M | ||
| Q3 24 | $29.8M | $91.8M | ||
| Q2 24 | $27.2M | $107.0M | ||
| Q1 24 | $-12.3M | $-125.2M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $37.6M | — | ||
| Q2 25 | $38.4M | — | ||
| Q1 25 | $-37.0M | — | ||
| Q4 24 | $56.1M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $-38.6M | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 7.6% | — | ||
| Q1 25 | -8.1% | — | ||
| Q4 24 | 11.8% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | -7.8% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | 1.52× | 3.39× | ||
| Q3 25 | 2.08× | 1.91× | ||
| Q2 25 | 3.08× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 1.31× | 4.72× | ||
| Q2 24 | 1.01× | — | ||
| Q1 24 | -0.95× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
